In summary, our study demonstrates that Curcumol inhibits colorectal cancer (CRC) progression by activating the VHL/HIF-1α pathway, suppressing glycolysis and lactate production, and improving tumor microenvironment. The gene discussed is VHL; the disease is neoplasm.